CLN3 Gene: Batten Disease Ceroid-Lipofuscinosis Neuronal 3

Genetic insights into CLN3, a key player in neuronal ceroid lipofuscinosis and lysosomal function.

Gene Information Card

Symbol CLN3
Full Name CLN3 lysosomal/endosomal transmembrane protein, battenin
Gene Type protein coding
Chromosomal Location 16p11.2
NCBI Gene ID 1201 ncbi.nlm.nih.gov/gene/1201
Ensembl ID ENSG00000171862
UniProt ID Q13286
OMIM ID 607042
HGNC ID 2074
Aliases BTS, JNCL, Batten disease, ceroid-lipofuscinosis neuronal 3

Description

The CLN3 gene encodes battenin, a transmembrane protein primarily localized to lysosomes and endosomes. It is involved in lysosomal pH regulation, autophagy, and intracellular trafficking. Mutations in CLN3 cause juvenile neuronal ceroid lipofuscinosis (Batten disease), a progressive neurodegenerative disorder characterized by accumulation of autofluorescent lipopigments in neurons and other cells.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Juvenile neuronal ceroid lipofuscinosis (Batten disease) Loss-of-function mutations lead to defective lysosomal function, impaired autophagy, and accumulation of ceroid lipofuscin. ClinVar, OMIM
Retinitis pigmentosa (isolated) Some CLN3 variants may cause retinal degeneration without full neurological symptoms. ClinVar, literature
Neuronal ceroid lipofuscinosis (other forms) Compound heterozygous mutations can present with atypical phenotypes. OMIM, ClinVar

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 10.2 Medium
Testis 8.5 Medium
Kidney 7.8 Low
Liver 6.1 Low
Heart 5.4 Low
Cell Line Expression
Cell Line nTPM Notes
SH-SY5Y (neuroblastoma) 12.3 High expression; used in neuronal studies
HeLa 8.7 Moderate expression
HEK293 7.9 Moderate expression
HepG2 5.2 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.462_463del (p.Gly154GlufsTer38) Frameshift Most common in Northern European populations (~70% of alleles) Loss of function; truncated protein
c.1054C>T (p.Arg352Trp) Missense Rare Likely loss of function; altered protein stability
c.791_792del (p.Phe264LeufsTer18) Frameshift Rare Loss of function; premature stop
c.1A>G (p.Met1?) Start codon loss Very rare Loss of function; no protein synthesis
Mutation functional classification

Loss of Function (LOF)

Most CLN3 mutations are loss-of-function, leading to reduced or absent battenin protein, causing lysosomal dysfunction and neurodegeneration.

Gain of Function (GOF)

No evidence of gain-of-function mutations for CLN3.

Dominant Negative (DN)

Not reported; CLN3 disease is autosomal recessive, so dominant-negative effects are unlikely.

Gene Ontology (GO)

• lysosomal membrane • endosome membrane
• protein binding • identical protein binding
• autophagy • lysosomal pH regulation
• intracellular protein transport • response to oxidative stress

Pathways

Lysosomal degradation pathway
Autophagy pathway
mTOR signaling (indirect)
Endosomal sorting complex required for transport (ESCRT) pathway (interaction)

Protein Summary

Battenin (CLN3) is a 438-amino acid transmembrane protein with six predicted transmembrane domains. It localizes to lysosomes and endosomes, where it regulates pH and vesicular trafficking. It interacts with proteins such as Hook1 and CTSD (cathepsin D). Defects in battenin lead to accumulation of subunit c of mitochondrial ATP synthase and other autofluorescent materials, characteristic of Batten disease.

Related Products

Product name Cat.No. Species Gene ID
CLN3 Knockout HEK293 Cell Line EDJ-KQ4292 Human 1201 Details Get a Quote
CLN3 Knockout HeLa Cell Line EDJ-KQ18209 Human 1201 Details Get a Quote
CLN3 Knockout HCT 116 Cell Line EDJ-KQ25483 Human 1201 Details Get a Quote
CLN3 Knockout A-549 Cell Line EDJ-KQ26780 Human 1201 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: